Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) has provided an update.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a board meeting scheduled for August 22, 2025, to consider and approve the unaudited interim results for the first half of the year and discuss the potential recommendation of an interim dividend. This meeting could impact the company’s financial strategy and shareholder returns, reflecting its ongoing commitment to transparency and shareholder engagement.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the medical technology industry. The company focuses on developing and providing medical technology solutions, although specific products or services are not detailed in the announcement.
Average Trading Volume: 1,025,807
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$9.2B
See more data about 2291 stock on TipRanks’ Stock Analysis page.